Following the commencement of Malaysia’s National COVID-19 Immunisation Programme on 24 Feb 2021, Manulife Insurance Berhad (MIB) will be introducing a complimentary Post COVID-19 Vaccination Support benefit to the person covered under the medical plans* offered by MIB.
|24 February 2021 until 31 December 2021|
Reimbursement of medical bills incurred due to serious adverse effect(s) from immunisation (“AEFI”) within 14 days after receiving an approved COVID-19 Vaccine, capped at maximum limit of RM5,000 per life.
|*Eligibility||Person covered under the medical plan offered by MIB that does not cover post COVID-19 vaccination, i.e. medical plans that carry an exclusion which excludes any cost of hospitalisation due to preventive treatment/preventive medicines.|
|Term & Conditions||
Here are some FAQs on the Post COVID-19 Vaccination Support for more information:
This benefit is designed for our customers’ whose medical plans do not cover any medical conditions that is due to post COVID-19 vaccination. For those customers with medical plan without the exclusion of preventive treatment/preventive medicines, they are covered for post COVID-19 vaccination as per Benefit Schedule of the respective medical policies.
Yes. This benefit is subject to the usual 30-day waiting period as stated in the respective medical plan’s policy contract.
This benefit is covered for government and private hospitals.
For any questions, please contact our customer service officers, we will be happy to assist you.